EBRC has been active in clinical trials for over 13 years and continues to be a site that has been involved in landmark studies involving the treatment of age-related macular degeneration, diabetic retinopathy and retinal vein occlusions. EBRC continues to dedicate our time and efforts toward promoting the advancement in retinal research and improving our surgical and medical care for each of our patients.

Our research team carefully evaluates each research study and selects well-designed and safe clinical studies that will not only benefit each of our participating patients, but also aid in the future discovery of treatment for retinal diseases.